Renal Unit, Royal Hobart Hospital, Tasmania; School of Medicine, University of Tasmania, Tasmania; Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), Adelaide, Australia.
School of Medicine, University of Auckland, Auckland, New Zealand; Department of Renal Medicine, Counties Manukau District Health Board, Auckland, New Zealand.
Am J Kidney Dis. 2017 Oct;70(4):570-575. doi: 10.1053/j.ajkd.2017.05.014. Epub 2017 Jun 30.
Bleeding from dialysis vascular access (arteriovenous fistulas, arteriovenous grafts, and vascular catheters) is uncommon. Death from these bleeds is rare and likely to be under-reported, with incident rates of fewer than 1 episode for every 1,000 patient-years on dialysis, meaning that dialysis units may experience this catastrophic event only once a decade. There is an opportunity to learn from (and therefore prevent) these bleeding deaths. We reviewed all reported episodes of death due to vascular access bleeding in Australia and New Zealand over a 14-year period together with individual dialysis units' root cause analyses on each event. In this perspective, we provide a clinically useful summary of the evidence and knowledge gained from these rare events. Our conclusion is that death due to dialysis vascular access hemorrhage is an uncommon, catastrophic, but potentially preventable event if the right policies and procedures are put in place.
透析血管通路(动静脉瘘、动静脉移植物和血管导管)出血并不常见。这些出血导致的死亡很少见,而且可能报告不足,每 1000 个透析患者中每年发生不到 1 例,这意味着透析单位可能每十年才会经历一次这种灾难性事件。我们有机会从(并因此预防)这些出血死亡中吸取教训。我们回顾了澳大利亚和新西兰在 14 年期间报告的所有因血管通路出血导致的死亡事件,以及每个事件中各个透析单位的根本原因分析。在这篇观点文章中,我们提供了从这些罕见事件中获得的具有临床应用价值的证据和知识总结。我们的结论是,如果制定了正确的政策和程序,透析血管通路出血导致的死亡是一种罕见但灾难性的,但可预防的事件。